Rubicon Research rose 1.02% to Rs 879 after it has announced the acquisition of an 85% equity stake in Arinna Lifesciences, a branded pharmaceutical marketing company focused on the CNS and neuro-psychiatric segment in...
Pharmaceutical
Everstone invests $270 million in Apothecon Group for a significant stake
Singapore-based private equity firm Everstone Capital will invest close to $270 million for a significant stake in Apothecon Group, which includes India-based Apothecon and US-based Navinta, it said in a statement on...
Sun Pharma closes in on Organon buy, gets set for $12 billion binding bid
Sun Pharmaceutical Industries has decided to proceed with a binding offer of $12 billion for Organon & Co, taking the company to the final stages of its most ambitious overseas acquisition bid as it looks to become...
IHH Healthcare aims to hike its stake in Fortis to 50%: CEO Prem Kumar Nair
Even as legal battles continue to simmer in the background, IHH Healthcare, one of Asia’s largest hospital groups, has identified India as a key growth market, with its sights firmly set on becoming one of the...
Gilead to buy Germany’s Tubulis for up to $5 billion to boost cancer pipeline
Gilead said on Tuesday it would acquire Germany-based Tubulis GmbH for up to $5 billion, as it looks to strengthen its cancer drugs pipeline. This marks the latest in Gilead’s acquisition spree. The company has...
Neurocrine expands into metabolic diseases with $2.9 billion Soleno buyout
Neurocrine Biosciences will acquire rare-disease drugmaker Soleno Therapeutics for $2.9 billion in cash, the companies said on Monday, marking the neuroscience-focused drugmaker’s expansion into metabolic...
Koye Pharma next on Warburg’s health play
Global private equity fund Warburg Pincus is in advanced discussions to acquire Mumbai-based Koye Pharma, a drugmaker that has built its presence across women’s health, respiratory care, and anti-diabetes drugs...
Corona Remedies acquires Wokadine from DR Reddy’s Laboratories
Corona Remedies announced the acquisition of the Wokadine brand from Dr. Reddy’s Laboratories to strengthen its presence in targeted specialty segment and offer wider accessibility. The Wokadine brand is an...
Bankruptcy court admits BSE-listed Supha Pharmachem under Insolvency Resolution Process
The bankruptcy court in Mumbai has admitted the listed pharma firm, Supha Pharmachem (formerly Remedium Lifecare), to the Corporate Insolvency Resolution Process (CIRP) and has appointed Rajesh Jhunjhunwala as the...
Bankruptcy court admits BSE-listed Supha Pharmachem under Insolvency Resolution Process
The bankruptcy court in Mumbai has admitted the listed pharma firm, Supha Pharmachem (formerly Remedium Lifecare), to the Corporate Insolvency Resolution Process (CIRP) and has appointed Rajesh Jhunjhunwala as the...
Novartis to pay up to $2 billion for US biotech firm Excellergy
Swiss drugmaker Novartis will buy California-based biotech company Excellergy in a deal worth up to $2 billion, it said on Friday, extending its anti-allergy range and in line with plans to increase its U.S. focus. A...
US-based Warburg Pincus in talks to buy Maneesh Pharma unit in Rs 1,800 crore deal
US-based private equity firm Warburg Pincus is in advanced discussions to acquire the formulations business of Mumbai-based Maneesh Pharmaceuticals in a deal valued around ₹1,600–1,800 crore, sources familiar with the...
